-
Changes and trends in the global drug R&D pipeline in 2021
The outbreak of the new crown epidemic and the restrictions on social isolation brought about by it have brought the development of many industries ar...
2021-11-04 16:39 -
Analysis of domestic veterinary drug raw materials market in the 44th week of 2021
The prices of ceftiofur sodium and ceftiofur hydrochloride have risen slightly. Since last year, many companies have been put into production one afte...
2021-11-03 16:37 -
Researchers successfully analyzed the environmental degradation products of the pesticide pyriconazo...
Recently, the pesticide application risk control innovation team of the Institute of Plant Protection of the Chinese Academy of Agricultural Sciences ...
2021-11-01 11:59 -
7.3 billion doses of COVID-19 vaccine worldwide, half of which are Chinese vaccines
On October 14, 2021, Nature published a news commentary, pointing out that the Chinese-made new crown vaccine has played a vital role in the global ep...
2021-10-29 17:00 -
Are there possible adverse reactions during the use of ofloxacin
When taking the drug ofloxacin, we should pay attention to some adverse reactions or contraindications that need to be paid attention to, and if there...
2021-10-29 14:22 -
Market analysis of veterinary drug feed ingredients
The market for veterinary drug raw materials continued to be strong.
2021-10-25 13:37 -
Analysis of domestic veterinary drug raw materials market in the 42nd week of 2021 Part 2
The price of albendazole rose, and the market quoted price was 173, which was the same as the price of the same period last year.
2021-10-21 13:33 -
Analysis of domestic veterinary drug raw materials market in the 42nd week of 2021
After the API China meeting, the explosive full jump mode was launched. Amoxicillin, ampicillin, and penicillin potassium industrial salt are still on...
2021-10-21 11:58 -
The price of Merck’s COVID-19 specific drug is 40 times the cost; Fosun Pharma sells its diagnostic...
A course of treatment is 700 dollars! The price of Merck's new crown drug is 40 times the cost. Molnupiravir, an oral new crown drug developed by the ...
2021-10-11 09:45 -
FDA approves the first topical JAK inhibitor to treat atopic dermatitis
On September 21, Incyte announced that the FDA approved Opzelura (ruxolitinib) cream for short-term and non-continuous long-term treatment of non-immu...
2021-09-24 10:15
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
- BASF Launches Second Round of ... Jul 24, 2025
Related Products
Related Producers
